Lv1
30 积分 2021-03-31 加入
Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study
17天前
已完结
Antibody–drug conjugates for cancer
28天前
已完结
Transferrin receptor targeting chimeras for membrane protein degradation
1个月前
已完结
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
1个月前
已完结
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
1个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
3个月前
已完结
Cancer therapy with antibodies
3个月前
已完结
Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor
5个月前
已完结
Significance of Selective Protein Degradation in the Development of Novel Targeted Drugs and Its Implications in Cancer Therapy
6个月前
已完结
JAK/STAT in leukemia: a clinical update
6个月前
已完结
皖公网安备34019202002308
